Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01531894 |
| Title | Continuation Study of the Oral AKT Inhibitor GSK2110183 |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | IRL | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Baltimore | Maryland | 21231 | United States | Details | |
| Novartis Investigative Site | Boston | Massachusetts | 02115 | United States | Details | |
| Novartis Investigative Site | New York | New York | 10029 | United States | Details | |
| Novartis Investigative Site | New York | New York | 10065 | United States | Details | |
| Novartis Investigative Site | Melbourne | Victoria | 3004 | Australia | Details | |
| Novartis Investigative Site | Toronto | Ontario | M5G 1Z6 | Canada | Details | |
| Novartis Investigative Site | Galway | Ireland | Details | |||
| Novartis Investigative Site | Seoul | 110-744 | Korea, Republic of | Details |